AU2016274785A1 - Osteogenic graft forming unit - Google Patents

Osteogenic graft forming unit Download PDF

Info

Publication number
AU2016274785A1
AU2016274785A1 AU2016274785A AU2016274785A AU2016274785A1 AU 2016274785 A1 AU2016274785 A1 AU 2016274785A1 AU 2016274785 A AU2016274785 A AU 2016274785A AU 2016274785 A AU2016274785 A AU 2016274785A AU 2016274785 A1 AU2016274785 A1 AU 2016274785A1
Authority
AU
Australia
Prior art keywords
cell
composition
cells
progenitor
chondrogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016274785A
Other languages
English (en)
Inventor
Brent Atkinson
Francois Binette
David Larocca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthocyte Corp
Original Assignee
Orthocyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthocyte Corp filed Critical Orthocyte Corp
Publication of AU2016274785A1 publication Critical patent/AU2016274785A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2016274785A 2015-06-09 2016-06-09 Osteogenic graft forming unit Abandoned AU2016274785A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562172808P 2015-06-09 2015-06-09
US62/172,808 2015-06-09
PCT/US2016/036778 WO2016201154A1 (en) 2015-06-09 2016-06-09 Osteogenic graft forming unit

Publications (1)

Publication Number Publication Date
AU2016274785A1 true AU2016274785A1 (en) 2017-12-07

Family

ID=57504258

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016274785A Abandoned AU2016274785A1 (en) 2015-06-09 2016-06-09 Osteogenic graft forming unit

Country Status (7)

Country Link
US (1) US20180325958A1 (enExample)
EP (1) EP3307287A4 (enExample)
JP (1) JP6875297B2 (enExample)
AU (1) AU2016274785A1 (enExample)
CA (1) CA2988778A1 (enExample)
HK (1) HK1254314A1 (enExample)
WO (1) WO2016201154A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
WO2018115871A1 (en) * 2016-12-20 2018-06-28 The University Of Birmingham Composition and method for bone production
JP7204730B2 (ja) * 2017-03-31 2023-01-16 セラム バイオメディカル， インコーポレイテッド 生体適合性馴化細胞培地組成物およびその使用
CN108452378B (zh) * 2018-02-08 2020-10-23 中山大学附属第一医院 一种3d生物打印成型方法
CN108310463B (zh) * 2018-02-08 2020-10-23 中山大学附属第一医院 一种3d打印生物墨水及其制备方法
KR102232283B1 (ko) * 2018-07-26 2021-03-25 에이비온 주식회사 연골세포 분화 마커
CN109568665B (zh) * 2018-12-28 2021-12-10 中国医科大学附属第一医院 负载脂肪干细胞外泌体的温敏型可注射水凝胶及其制备方法和应用
CA3137836C (en) * 2019-04-23 2024-04-09 Cellatoz Therapeutics, Inc. Method for regulation of selective differentiation of musculoskeletal stem cells
KR102236635B1 (ko) * 2019-09-04 2021-04-13 경북대학교 산학협력단 Meox2 억제제를 유효성분으로 포함하는 발치와 골 재생 촉진용 조성물
KR102104933B1 (ko) * 2019-10-31 2020-04-27 주식회사 라이프온 줄기세포 유래 엑소좀을 함유하는 치아 재강화 또는 치아골 이식재 조성물 및 그 제조방법
CN110684710A (zh) * 2019-11-23 2020-01-14 吉林省蔚来生物科技有限公司 一种骨膜生物支架与异体种子细胞复合的培养方法
JP2021159499A (ja) * 2020-04-01 2021-10-11 株式会社Dr.Cherry 骨形成を促進することに用いられる新生骨の支持体
KR102463245B1 (ko) * 2020-06-19 2022-11-07 동국대학교 산학협력단 Mettl7a 과발현 줄기세포를 포함하는 골재생용 조성물, 이를 제조하는 방법 및 이를 포함하는 세포치료제
CN113249332A (zh) * 2021-07-15 2021-08-13 北京大学第三医院（北京大学第三临床医学院） 一种alpl基因缺失骨髓间充质干细胞的建立方法
EP4230232A1 (en) 2022-02-16 2023-08-23 Hacettepe Üniversitesi Binding of calcium phosphate bioceramic and exosomes via annexin v mediator molecule
CN115957378B (zh) * 2023-02-08 2024-10-22 上海交通大学医学院附属瑞金医院 一种骨修复组合物及其制备方法和应用
CN118028212B (zh) * 2024-04-12 2024-06-18 广东医科大学附属医院 土元外泌体在制备抗骨质疏松药物中的应用、药物
CN120209114A (zh) * 2025-03-07 2025-06-27 首都医科大学 一种含有penk蛋白的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1722765A2 (en) * 2004-01-28 2006-11-22 The Regents of The University of Michigan Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
CH700138B1 (it) * 2008-12-19 2012-12-14 Ind Biomediche Insubri S A Matrice per impianto osseo e procedimento di preparazione della stessa.
WO2013010045A1 (en) * 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
CN104487569A (zh) * 2012-05-10 2015-04-01 生物材料细胞公司 间充质干细胞的成骨分化
US20140178988A1 (en) * 2012-10-08 2014-06-26 Biotime, Inc. Differentiated Progeny of Clonal Progenitor Cell Lines
AU2014284440B2 (en) * 2013-07-01 2018-07-19 Amit Prakash Govil Soft tissue implant
CA2923002C (en) * 2013-09-02 2022-12-13 Muffin Incorporated Products comprising an extracellular matrix tissue material and osteogenic protein

Also Published As

Publication number Publication date
CA2988778A1 (en) 2016-12-15
EP3307287A1 (en) 2018-04-18
EP3307287A4 (en) 2018-12-19
JP2018520750A (ja) 2018-08-02
US20180325958A1 (en) 2018-11-15
HK1254314A1 (zh) 2019-07-19
WO2016201154A1 (en) 2016-12-15
JP6875297B2 (ja) 2021-05-19

Similar Documents

Publication Publication Date Title
US20180325958A1 (en) Osteogenic graft forming unit
US11357889B2 (en) Native soft tissue matrix for therapeutic applications
Fitzpatrick et al. Cell-derived matrices for tissue engineering and regenerative medicine applications
Liu et al. Robust bone regeneration through endochondral ossification of human mesenchymal stem cells within their own extracellular matrix
US20100267143A1 (en) Method for Surface Modification of Polymeric Scaffold for Stem Cell Transplantation Using Decellularized Extracellular Matrix
Li et al. Inhibition of osteoclastogenesis by stem cell-derived extracellular matrix through modulation of intracellular reactive oxygen species
TW202136500A (zh) 用於預防及治療組織疾病之生物材料
Ivkovic et al. Regenerative medicine and tissue engineering in orthopaedic surgery
WO2012142569A2 (en) Decellularized extracellular matrix
KR100920951B1 (ko) 미분화 인간 지방조직 유래 줄기세포를 포함하는 골 재생용복합 지지체
Song et al. The synergistic effect of micro-topography and biochemical culture environment to promote angiogenesis and osteogenic differentiation of human mesenchymal stem cells
Zhao et al. Chondrogenesis by bone marrow‐derived mesenchymal stem cells grown in chondrocyte‐conditioned medium for auricular reconstruction
Chandramohan et al. Assessment of human ovarian follicular fluid derived mesenchymal stem cells in chitosan/PCL/Zn scaffold for bone tissue regeneration
JP2016028756A (ja) 足場
CN111107887B (zh) 包含脂肪干细胞的生物材料及其制备方法
Tadokoro et al. Bone morphogenetic protein‐2 in biodegradable gelatin and β‐tricalcium phosphate sponges enhances the in vivo bone‐forming capability of bone marrow mesenchymal stem cells
US20160067377A1 (en) Stem Cell Seeded Natural Substrates and Methods Relating Thereto
Nie et al. Engineering a multiphasic, integrated graft with a biologically developed cartilage–bone interface for osteochondral defect repair
CN112203702A (zh) 富含脱细胞化骨细胞外基质水凝胶的脱细胞化骨生物材料
JP2016537320A (ja) 骨形成幹細胞を含む骨移植片及びそれに関連する方法
Jamalpoor et al. Comparative evaluation of morphology and osteogenic behavior of human Wharton's jelly mesenchymal stem cells on 2D culture plate and 3D biomimetic scaffold
KR101851019B1 (ko) 양성 연골종양세포를 이용하여 제조한 연골기질 및 이의 제조방법
US11471562B2 (en) Cartilage material having minimal hypertrophy and robust integration capacity, and uses therefor
US20160206781A1 (en) Methods and compositions for the production of composites for bone implantation
US20120207715A1 (en) Methods and systems for storing and prolonging viability of matrix dependent cells

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application